Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Hoffmann-La Roche
Age
18–any
Sex
FEMALE
Healthy volunteers
Not accepted
You may be eligible if
Women with histologically confirmed breast cancer with known human epidermal receptor-2 (HER2) and hormone status
Newly diagnosed CNS metastasis with at least one brain lesion measuring greater than or equal to (\>/=) 1 centimeter (cm) or two lesions measuring \>/= 0.5 to less than (\<) 1 cm in longest dimension
You may not be if
Eastern cooperative oncology group (EOCG) performance status 0 to 2
Prior treatment of brain metastases
Leptomeningeal disease
Known contra-indication to radiotherapy or magnetic resonance imaging (MRI) or capecitabine
Clareo Health | A Study of Whole Brain Radiation Therapy and Capecitabine in Breast Cancer Participants With Newly Diagnosed Brain Metastasis
